Top 5 Stocks to Buy Now
→ SpaceX IPO hides a much bigger story (From Weiss Ratings) (Ad)tc pixel Free XPER Stock Alerts

Xperi (XPER) Financials

Xperi logo
$8.04 +0.07 (+0.88%)
Closing price 03:58 PM Eastern
Extended Trading
$7.94 -0.11 (-1.31%)
As of 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Xperi

Annual Income Statements for Xperi

This table shows Xperi's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -138 -176 -757 -137 -14
Consolidated Net Income / (Loss)		 -141 -179 -761 -140 -0.87
Net Income / (Loss) Continuing Operations		 -141 -179 -761 -140 -0.87
Total Pre-Tax Income 		-151 -160 -748 -130 12
Total Operating Income		 -153 -162 -749 -130 -87
Total Gross Profit		 298 361 379 403 380
Total Revenue		 376 486 502 521 494
Operating Revenue		 376 486 502 521 494
Total Cost of Revenue		 78 126 123 119 114
Operating Cost of Revenue		 78 126 123 119 114
Total Operating Expenses		 451 523 1,129 532 467
Selling, General & Admin Expense		 173 200 217 233 218
Research & Development Expense		 163 195 216 223 191
Depreciation Expense		 17 23 21 17 13
Amortization Expense		 98 105 62 58 43
Impairment Charge		 0.00 0.00 612 1.71 1.54
Total Other Income / (Expense), net		 1.54 1.59 1.82 -0.01 99
Interest Expense		 - - 1.51 3.00 3.01
Interest & Investment Income		 - - 3.33 2.99 0.83
Other Income / (Expense), net		 1.54 1.59 0.00 0.00 101
Income Tax Expense		 -9.74 19 14 10 12
Net Income / (Loss) Attributable to Noncontrolling Interest		 -2.97 -3.46 -3.72 -3.08 13
Basic Earnings per Share		 ($3.29) ($4.18) ($18.02) ($3.18) ($0.31)
Weighted Average Basic Shares Outstanding		 42.02M 42.02M 42.03M 43.01M 45.06M
Diluted Earnings per Share		 ($3.29) ($4.18) ($18.02) ($3.18) ($0.31)
Weighted Average Diluted Shares Outstanding		 42.02M 42.02M 42.03M 43.01M 45.06M
Weighted Average Basic & Diluted Shares Outstanding		 - - 42.08M 44.27M 44.39M

Quarterly Income Statements for Xperi

This table shows Xperi's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -401 -297 -32 -38 -41 -25 -13 -30 -17 46
Consolidated Net Income / (Loss)		 -402 -298 -33 -39 -42 -25 -13 -31 -20 63
Net Income / (Loss) Continuing Operations		 -402 -298 -33 -39 -42 -25 -13 -31 -20 63
Total Pre-Tax Income 		-400 -297 -33 -34 -32 -30 -9.10 -21 -17 59
Total Operating Income		 -399 -299 -34 -35 -31 -30 -32 -22 -19 -14
Total Gross Profit		 90 98 99 96 104 104 89 91 105 95
Total Revenue		 122 136 127 127 130 137 119 120 133 122
Operating Revenue		 122 136 127 127 130 137 119 120 133 122
Total Cost of Revenue		 31 37 28 31 26 34 30 29 27 28
Operating Cost of Revenue		 31 37 28 31 26 34 30 29 27 28
Total Operating Expenses		 489 397 133 131 135 133 121 113 124 109
Selling, General & Admin Expense		 57 61 58 56 60 60 56 53 56 52
Research & Development Expense		 57 58 55 56 56 56 50 45 54 42
Depreciation Expense		 4.99 4.80 4.09 4.20 4.25 4.10 3.58 3.28 2.92 2.86
Amortization Expense		 17 16 15 15 15 13 11 11 11 10
Impairment Charge		 354 258 1.10 0.00 0.00 0.61 0.00 0.00 0.00 1.54
Total Other Income / (Expense), net		 -0.53 2.12 0.37 0.91 -1.34 0.05 23 0.54 1.62 73
Interest Expense		 - - 0.74 0.75 1.34 0.17 0.75 0.75 0.76 0.76
Other Income / (Expense), net		 -0.53 0.30 0.00 0.00 0.00 - 23 0.00 2.38 76
Income Tax Expense		 2.02 1.09 -0.29 5.09 9.69 -4.44 4.27 9.27 2.90 -3.99
Net Income / (Loss) Attributable to Noncontrolling Interest		 -0.89 -1.02 -0.94 -0.97 -0.65 -0.52 -0.25 -0.33 -3.03 17
Basic Earnings per Share		 ($9.54) ($7.06) ($0.76) ($0.90) ($0.96) ($0.56) ($0.29) ($0.67) ($0.37) $1.02
Weighted Average Basic Shares Outstanding		 42.02M 42.03M 42.22M 42.77M 43.32M 43.01M 44.52M 45.33M 45.68M 45.06M
Diluted Earnings per Share		 ($9.54) ($7.06) ($0.76) ($0.90) ($0.96) ($0.56) ($0.29) ($0.67) ($0.37) $1.02
Weighted Average Diluted Shares Outstanding		 42.02M 42.03M 42.22M 42.77M 43.32M 43.01M 44.52M 45.33M 45.68M 45.06M
Weighted Average Basic & Diluted Shares Outstanding		 - 42.08M 42.52M 43.30M 43.47M 44.27M 45.15M 45.81M 44.83M 44.39M

Annual Cash Flow Statements for Xperi

This table details how cash moves in and out of Xperi's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 38 35 39 -5.69 -24
Net Cash From Operating Activities		 -24 -23 -28 0.06 -55
Net Cash From Continuing Operating Activities		 -24 -23 -28 0.06 -55
Net Income / (Loss) Continuing Operations		 -141 -179 -761 -140 -0.87
Consolidated Net Income / (Loss)		 -141 -179 -761 -140 -0.87
Depreciation Expense		 17 23 21 17 13
Amortization Expense		 98 105 62 58 43
Non-Cash Adjustments To Reconcile Net Income		 29 49 645 52 -83
Changes in Operating Assets and Liabilities, net		 -26 -21 4.94 13 -27
Net Cash From Investing Activities		 27 -21 -65 -13 51
Net Cash From Continuing Investing Activities		 27 -21 -65 -13 51
Purchase of Property, Plant & Equipment		 -6.60 -8.89 -14 -13 -17
Acquisitions		 33 -13 -51 -0.19 -0.20
Divestitures		 - - 0.00 0.00 68
Net Cash From Financing Activities		 34 83 136 7.05 -19
Net Cash From Continuing Financing Activities		 34 83 136 7.05 -19
Repurchase of Common Equity		 - - 0.00 0.00 -20
Issuance of Common Equity		 - 0.00 0.00 12 7.86
Other Financing Activities, net		 34 83 136 -4.88 -7.22
Effect of Exchange Rate Changes		 1.37 -3.33 -3.03 0.13 0.00
Cash Interest Paid		 0.00 0.00 0.76 3.00 3.01
Cash Income Taxes Paid		 8.58 12 13 21 19

Quarterly Cash Flow Statements for Xperi

This table details how cash moves in and out of Xperi's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Change in Cash & Equivalents		 152 -125 -49 1.46 19 23 -59 -2.74 -20 58
Net Cash From Operating Activities		 11 -17 -43 -1.53 24 21 -50 -2.13 -4.65 1.23
Net Cash From Continuing Operating Activities		 11 -17 -43 -1.53 24 21 -50 -2.13 -4.65 1.23
Net Income / (Loss) Continuing Operations		 -402 -298 -33 -39 -42 -25 -13 -31 -20 63
Consolidated Net Income / (Loss)		 -402 -298 -33 -39 -42 -25 -13 -31 -20 63
Depreciation Expense		 4.99 4.80 4.09 4.20 4.25 4.10 3.58 3.28 2.92 2.86
Amortization Expense		 17 16 15 15 15 13 11 11 11 10
Non-Cash Adjustments To Reconcile Net Income		 360 261 7.94 20 11 13 -13 -2.40 -6.24 -62
Changes in Operating Assets and Liabilities, net		 31 -0.64 -37 -1.05 36 16 -39 17 7.57 -13
Net Cash From Investing Activities		 -54 -3.75 -3.93 -2.27 -3.38 -3.35 -4.71 -3.73 -4.42 64
Net Cash From Continuing Investing Activities		 47 -105 -3.93 -2.27 -3.38 -3.35 -4.71 -3.73 -4.42 64
Purchase of Property, Plant & Equipment		 -3.36 -3.69 -3.86 -2.25 -3.32 -3.32 -4.45 -3.68 -4.35 -4.28
Acquisitions		 50 -101 -0.07 -0.02 -0.06 -0.04 -0.27 -0.05 -0.07 0.19
Net Cash From Financing Activities		 92 -0.29 -2.92 5.64 -1.19 5.52 -4.67 3.07 -11 -7.03
Net Cash From Continuing Financing Activities		 92 -0.29 -2.92 5.64 -1.19 5.52 -4.67 3.07 -11 -7.03
Repurchase of Common Equity		 - - - - - - - - - -9.99
Issuance of Common Equity		 - - 0.00 5.85 - 6.08 0.00 4.33 - 3.53
Other Financing Activities, net		 92 -0.29 -2.92 -0.21 -1.19 -0.56 -4.67 -1.26 -0.72 -0.57
Cash Interest Paid		 - 0.76 1.50 - 0.75 0.76 0.76 0.75 0.75 0.76
Cash Income Taxes Paid		 1.04 3.96 1.60 8.51 5.40 5.83 4.24 4.97 3.05 6.87

Annual Balance Sheets for Xperi

This table presents Xperi's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 1,229 737 674 668
Total Current Assets		 277 332 317 305
Cash & Equivalents		 121 160 142 131
Accounts Receivable		 130 130 120 142
Prepaid Expenses		 - 42 39 32
Other Current Nonoperating Assets		 - 0.00 16 0.00
Plant, Property, & Equipment, net		 57 48 42 44
Total Noncurrent Assets		 894 357 315 318
Noncurrent Note & Lease Receivables		 3.83 4.29 0.00 30
Intangible Assets		 271 264 207 164
Noncurrent Deferred & Refundable Income Taxes		 1.85 2.10 5.09 7.23
Other Noncurrent Operating Assets		 81 86 91 118
Other Noncurrent Nonoperating Assets		 - 0.00 12 0.00
Total Liabilities & Shareholders' Equity		 1,229 737 674 668
Total Liabilities		 213 288 287 239
Total Current Liabilities		 120 150 165 185
Short-Term Debt		 - - 0.00 50
Accounts Payable		 7.36 15 21 17
Accrued Expenses		 84 110 110 94
Current Deferred Revenue		 28 25 28 24
Other Current Nonoperating Liabilities		 - 0.00 6.19 0.00
Total Noncurrent Liabilities		 93 138 121 53
Long-Term Debt		 0.00 50 50 0.00
Noncurrent Deferred Revenue		 24 19 19 21
Noncurrent Deferred & Payable Income Tax Liabilities		 14 13 6.98 1.49
Other Noncurrent Operating Liabilities		 55 56 35 31
Other Noncurrent Nonoperating Liabilities		 - 0.00 9.81 0.00
Commitments & Contingencies		 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,016 449 387 429
Total Preferred & Common Equity		 1,025 463 404 429
Preferred Stock		 0.00 0.00 0.00 0.00
Total Common Equity		 1,025 463 404 429
Common Stock		 0.00 1,136 1,213 1,275
Retained Earnings		 0.00 -669 -805 -839
Accumulated Other Comprehensive Income / (Loss)		 -0.68 -4.12 -2.87 -6.08
Noncontrolling Interest		 -9.21 -14 -17 0.00

Quarterly Balance Sheets for Xperi

This table presents Xperi's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024
Total Assets		 687 671 664 630 619 616
Total Current Assets		 297 288 296 272 266 259
Cash & Equivalents		 111 112 132 95 92 73
Accounts Receivable		 140 136 125 134 138 147
Prepaid Expenses		 - 40 39 43 36 38
Other Current Nonoperating Assets		 - - - 0.00 0.00 1.31
Plant, Property, & Equipment, net		 47 46 45 42 42 44
Total Noncurrent Assets		 343 337 324 317 311 314
Noncurrent Note & Lease Receivables		 9.56 17 22 44 29 29
Intangible Assets		 250 235 220 196 185 174
Noncurrent Deferred & Refundable Income Taxes		 2.28 2.40 2.47 4.89 4.95 5.06
Other Noncurrent Operating Assets		 81 82 79 72 92 105
Other Noncurrent Nonoperating Assets		 - - - 0.00 0.00 0.17
Total Liabilities & Shareholders' Equity		 687 671 664 630 619 616
Total Liabilities		 257 257 278 249 249 260
Total Current Liabilities		 126 127 151 130 133 201
Short-Term Debt		 - - - - - 50
Accounts Payable		 14 11 16 20 14 19
Accrued Expenses		 87 91 110 84 90 106
Current Deferred Revenue		 25 25 26 26 28 26
Other Current Nonoperating Liabilities		 - - - 0.00 0.00 0.07
Total Noncurrent Liabilities		 131 130 126 119 117 59
Long-Term Debt		 50 50 50 50 50 0.00
Noncurrent Deferred Revenue		 19 18 19 23 22 20
Noncurrent Deferred & Payable Income Tax Liabilities		 13 12 12 7.01 7.00 7.02
Other Noncurrent Operating Liabilities		 49 49 45 39 37 32
Other Noncurrent Nonoperating Liabilities		 - - - 0.00 0.00 0.01
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 431 414 386 382 370 356
Total Preferred & Common Equity		 446 431 403 399 389 377
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 446 431 403 399 389 377
Common Stock		 1,149 1,173 1,189 1,222 1,242 1,256
Retained Earnings		 -701 -739 -781 -819 -849 -876
Accumulated Other Comprehensive Income / (Loss)		 -2.64 -3.17 -5.49 -4.04 -4.38 -3.34
Noncontrolling Interest		 -15 -16 -17 -17 -19 -22

Annual Metrics And Ratios for Xperi

This table displays calculated financial ratios and metrics derived from Xperi's official financial filings.

Metric 2020 2021 2022 2023 2024
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - -
Revenue Growth		 0.00% 29.35% 3.24% 3.80% -5.30%
EBITDA Growth		 0.00% 10.54% -1,961.41% 91.71% 226.31%
EBIT Growth		 0.00% -6.10% -367.70% 82.70% 110.61%
NOPAT Growth		 0.00% -6.07% -363.10% 82.70% 107.20%
Net Income Growth		 0.00% -26.74% -325.07% 81.65% 99.38%
EPS Growth		 0.00% -27.05% -331.10% 82.35% 90.25%
Operating Cash Flow Growth		 0.00% 1.36% -21.29% 100.22% -89,358.06%
Free Cash Flow Firm Growth		 0.00% 0.00% 103.15% -209.51% -69.54%
Invested Capital Growth		 0.00% 0.00% -62.15% -16.50% 23.18%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.33% -2.92%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 82.69% 510.71%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 67.33% 117.80%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 67.50% 109.10%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 66.13% 99.03%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 67.15% 83.60%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 100.16% -54.12%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 40.13%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% -7.21% 5.06%
Profitability Metrics		 - - - - -
Gross Margin		 79.32% 74.18% 75.52% 77.25% 76.96%
EBITDA Margin		 -9.61% -6.65% -132.74% -10.60% 14.13%
Operating Margin		 -40.56% -33.26% -149.21% -24.87% -17.64%
EBIT Margin		 -40.16% -32.94% -149.21% -24.87% 2.79%
Profit (Net Income) Margin		 -37.57% -36.81% -151.56% -26.79% -0.18%
Tax Burden Percent		 93.55% 111.76% 101.82% 107.75% -7.51%
Interest Burden Percent		 100.00% 100.00% 99.76% 100.01% 84.16%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 107.51%
Return on Invested Capital (ROIC)		 0.00% -25.31% -85.02% -29.19% 2.07%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 83.73% 119.99% 16.48% 10.08%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -9.95% -18.91% -4.23% -2.28%
Return on Equity (ROE)		 0.00% -35.25% -103.92% -33.41% -0.21%
Cash Return on Invested Capital (CROIC)		 0.00% -225.31% 5.15% -11.20% -18.70%
Operating Return on Assets (OROA)		 0.00% -13.04% -76.25% -18.38% 2.05%
Return on Assets (ROA)		 0.00% -14.57% -77.45% -19.81% -0.13%
Return on Common Equity (ROCE)		 0.00% -35.57% -105.60% -34.67% -0.22%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -17.47% -164.26% -34.56% -0.20%
Net Operating Profit after Tax (NOPAT)		 -107 -113 -525 -91 6.53
NOPAT Margin		 -28.40% -23.29% -104.45% -17.41% 1.32%
Net Nonoperating Expense Percent (NNEP)		 0.00% -109.03% -205.01% -45.67% -8.01%
Return On Investment Capital (ROIC_SIMPLE)		 - - -105.13% -20.76% 1.36%
Cost of Revenue to Revenue		 20.68% 25.82% 24.48% 22.75% 23.04%
SG&A Expenses to Revenue		 45.89% 41.10% 43.28% 44.77% 44.18%
R&D to Revenue		 43.45% 40.06% 43.08% 42.74% 38.76%
Operating Expenses to Revenue		 119.88% 107.44% 224.73% 102.11% 94.60%
Earnings before Interest and Taxes (EBIT)		 -151 -160 -749 -130 14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -36 -32 -667 -55 70
Valuation Ratios		 - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.78 1.15 1.01
Price to Tangible Book Value (P/TBV)		 0.00 0.00 1.82 2.35 1.63
Price to Revenue (P/Rev)		 0.00 0.00 0.72 0.89 0.87
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 2.41% 1.12% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.70 1.25 1.01
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.47 0.68 0.71
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 5.03
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 25.51
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 53.71
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 5,708.36 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 7.46 0.00 0.00
Leverage & Solvency		 - - - - -
Debt to Equity		 0.00 0.00 0.11 0.13 0.12
Long-Term Debt to Equity		 0.00 0.00 0.11 0.13 0.00
Financial Leverage		 0.00 -0.12 -0.16 -0.26 -0.23
Leverage Ratio		 0.00 1.21 1.34 1.69 1.64
Compound Leverage Factor		 0.00 1.21 1.34 1.69 1.38
Debt to Total Capital		 0.00% 0.00% 10.02% 11.44% 10.44%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 10.44%
Long-Term Debt to Total Capital		 0.00% 0.00% 10.02% 11.44% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% -0.91% -2.89% -3.91% 0.00%
Common Equity to Total Capital		 0.00% 100.91% 92.87% 92.47% 89.56%
Debt to EBITDA		 0.00 0.00 -0.08 -0.91 0.72
Net Debt to EBITDA		 0.00 0.00 0.17 1.67 -1.15
Long-Term Debt to EBITDA		 0.00 0.00 -0.08 -0.91 0.00
Debt to NOPAT		 0.00 0.00 -0.10 -0.55 7.65
Net Debt to NOPAT		 0.00 0.00 0.21 1.01 -12.33
Long-Term Debt to NOPAT		 0.00 0.00 -0.10 -0.55 0.00
Altman Z-Score		 0.00 0.00 -2.89 -0.29 0.35
Noncontrolling Interest Sharing Ratio		 0.00% -0.91% -1.61% -3.77% -2.09%
Liquidity Ratios		 - - - - -
Current Ratio		 0.00 2.31 2.21 1.92 1.64
Quick Ratio		 0.00 2.09 1.93 1.59 1.47
Cash Flow Metrics		 - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -1,009 32 -35 -59
Operating Cash Flow to CapEx		 -360.20% -263.72% -200.22% 0.49% -330.23%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 21.03 -11.61 -19.63
Operating Cash Flow to Interest Expense		 0.00 0.00 -18.81 0.02 -18.40
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 -28.21 -4.23 -23.97
Efficiency Ratios		 - - - - -
Asset Turnover		 0.00 0.40 0.51 0.74 0.74
Accounts Receivable Turnover		 0.00 3.73 3.86 4.17 3.77
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 8.46 9.54 11.66 11.48
Accounts Payable Turnover		 0.00 17.06 11.06 6.64 6.01
Days Sales Outstanding (DSO)		 0.00 97.88 94.63 87.54 96.82
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 21.39 32.99 54.94 60.69
Cash Conversion Cycle (CCC)		 0.00 76.49 61.63 32.60 36.13
Capital & Investment Metrics		 - - - - -
Invested Capital		 0.00 895 339 283 349
Invested Capital Turnover		 0.00 1.09 0.81 1.68 1.56
Increase / (Decrease) in Invested Capital		 0.00 895 -556 -56 66
Enterprise Value (EV)		 0.00 0.00 237 354 351
Market Capitalization		 0.00 0.00 362 463 432
Book Value per Share		 $0.00 $24.39 $11.03 $9.30 $9.57
Tangible Book Value per Share		 $0.00 $5.18 $4.74 $4.54 $5.92
Total Capital		 0.00 1,016 499 437 479
Total Debt		 0.00 0.00 50 50 50
Total Long-Term Debt		 0.00 0.00 50 50 0.00
Net Debt		 0.00 -121 -110 -92 -81
Capital Expenditures (CapEx)		 6.60 8.89 14 13 17
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 36 22 9.72 39
Debt-free Net Working Capital (DFNWC)		 0.00 157 182 152 170
Net Working Capital (NWC)		 0.00 157 182 152 120
Net Nonoperating Expense (NNE)		 34 66 237 49 7.40
Net Nonoperating Obligations (NNO)		 0.00 -121 -110 -104 -81
Total Depreciation and Amortization (D&A)		 115 128 83 74 56
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 7.50% 4.36% 1.86% 7.89%
Debt-free Net Working Capital to Revenue		 0.00% 32.31% 36.24% 29.12% 34.34%
Net Working Capital to Revenue		 0.00% 32.31% 36.24% 29.12% 24.21%
Earnings Adjustments		 - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($18.02) ($3.18) ($0.31)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 42.03M 43.01M 45.06M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($18.02) ($3.18) ($0.31)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 42.03M 43.01M 45.06M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 42.08M 44.27M 44.39M
Normalized Net Operating Profit after Tax (NOPAT)		 -107 -113 -96 -90 -60
Normalized NOPAT Margin		 -28.40% -23.29% -19.12% -17.18% -12.13%
Pre Tax Income Margin		 -40.16% -32.94% -148.85% -24.87% 2.35%
Debt Service Ratios		 - - - - -
EBIT to Interest Expense		 0.00 0.00 -495.66 -43.21 4.57
NOPAT to Interest Expense		 0.00 0.00 -346.96 -30.25 2.17
EBIT Less CapEx to Interest Expense		 0.00 0.00 -505.05 -47.46 -1.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 -356.36 -34.50 -3.40
Payout Ratios		 - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% -2,300.35%

Quarterly Metrics And Ratios for Xperi

This table displays calculated financial ratios and metrics derived from Xperi's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 6.69% 0.53% 7.20% 1.26% -6.30% -5.74% 1.92% -10.84%
EBITDA Growth		 0.00% 0.00% -82.24% -504.26% 96.81% 95.58% 135.62% 53.11% 80.76% 705.41%
EBIT Growth		 0.00% 0.00% -18.27% -55.79% 92.23% 90.02% 72.05% 37.73% 47.91% 305.46%
NOPAT Growth		 0.00% 0.00% -16.16% -57.82% 92.22% 90.03% 3.79% 37.73% 40.24% 26.89%
Net Income Growth		 0.00% 0.00% -8.03% -27.07% 89.53% 91.51% 59.41% 22.19% 52.86% 348.74%
EPS Growth		 0.00% 0.00% -8.57% -25.00% 89.94% 92.07% 61.84% 25.56% 61.46% 282.14%
Operating Cash Flow Growth		 0.00% 0.00% -134.71% 60.77% 120.03% 220.74% -15.51% -39.84% -119.34% -94.05%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 102.72% 102.47% 87.82% -330.54%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% -16.50% -9.01% -7.00% 8.79% 23.18%
Revenue Q/Q Growth		 -3.62% 11.42% -6.41% 0.03% 2.77% 5.25% -13.40% 0.63% 11.12% -7.92%
EBITDA Q/Q Growth		 -14,017.44% 26.49% 94.68% -10.22% 25.36% -1.81% 142.70% -245.07% 69.37% 3,303.66%
EBIT Q/Q Growth		 -1,669.77% 25.25% 88.68% -4.71% 11.74% 4.02% 68.43% -133.23% 26.16% 478.55%
NOPAT Q/Q Growth		 -1,690.43% 25.07% 88.76% -4.71% 11.74% 4.02% -8.47% 32.23% 15.30% -17.43%
Net Income Q/Q Growth		 -1,196.70% 25.80% 88.95% -19.51% -6.88% 39.83% 47.18% -129.09% 35.26% 417.50%
EPS Q/Q Growth		 -1,225.00% 26.00% 89.24% -18.42% -6.67% 41.67% 48.21% -131.03% 44.78% 375.68%
Operating Cash Flow Q/Q Growth		 380.75% -256.69% -151.89% 96.46% 1,674.71% -14.02% -340.97% 95.71% -117.81% 126.44%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 4.20% 13.32% 110.73% -69.46% -12.99% -527.13% -103.10%
Invested Capital Q/Q Growth		 0.00% 0.00% 9.15% -4.77% -13.44% -7.21% 18.95% -2.66% 1.26% 5.06%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 74.18% 72.51% 78.09% 75.68% 79.74% 75.54% 74.96% 75.79% 79.32% 77.47%
EBITDA Margin		 -310.81% -205.06% -11.57% -12.75% -9.26% -8.96% 4.40% -6.34% -1.75% 60.85%
Operating Margin		 -328.14% -220.67% -26.49% -27.73% -23.81% -21.72% -27.20% -18.32% -13.96% -11.68%
EBIT Margin		 -328.57% -220.44% -26.49% -27.73% -23.81% -21.72% -7.90% -18.32% -12.17% 50.04%
Profit (Net Income) Margin		 -330.24% -219.91% -25.97% -31.03% -32.27% -18.45% -11.25% -25.61% -14.92% 51.46%
Tax Burden Percent		 100.51% 100.37% 99.12% 114.85% 129.90% 85.08% 146.95% 143.37% 117.12% 106.76%
Interest Burden Percent		 100.00% 99.39% 98.90% 97.42% 104.30% 99.83% 96.87% 97.53% 104.67% 96.31%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -6.76%
Return on Invested Capital (ROIC)		 0.00% -228.95% -51.16% -56.31% -56.82% -25.49% -27.67% -19.09% -15.61% -19.49%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -148.41% -20.12% -8.89% -6.93% -21.34% -45.16% 10.15% -2.66% -104.16%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 36.40% 2.84% 1.33% 1.46% 5.47% 5.89% -1.35% 0.38% 23.58%
Return on Equity (ROE)		 0.00% -192.55% -48.32% -54.97% -55.35% -20.02% -21.79% -20.44% -15.24% 4.09%
Cash Return on Invested Capital (CROIC)		 0.00% 9.38% 0.00% 0.00% 0.00% -11.20% -16.00% -16.45% -30.98% -18.70%
Operating Return on Assets (OROA)		 0.00% -112.66% -19.67% -21.11% -18.63% -16.05% -6.16% -14.37% -9.67% 36.84%
Return on Assets (ROA)		 0.00% -112.38% -19.28% -23.62% -25.24% -13.63% -8.77% -20.09% -11.85% 37.88%
Return on Common Equity (ROCE)		 0.00% -195.65% -50.05% -57.14% -57.75% -20.78% -22.66% -21.35% -16.02% 4.17%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% -171.25% -179.24% -102.29% 0.00% -30.09% -28.65% -23.62% 0.00%
Net Operating Profit after Tax (NOPAT)		 -279 -209 -24 -25 -22 -21 -23 -15 -13 -15
NOPAT Margin		 -229.70% -154.47% -18.54% -19.41% -16.67% -15.20% -19.04% -12.82% -9.77% -12.46%
Net Nonoperating Expense Percent (NNEP)		 0.00% -80.54% -31.03% -47.42% -49.89% -4.15% 17.48% -29.24% -12.96% 84.67%
Return On Investment Capital (ROIC_SIMPLE)		 - -41.96% - - - -4.77% - - - -3.18%
Cost of Revenue to Revenue		 25.82% 27.49% 21.91% 24.32% 20.26% 24.46% 25.04% 24.21% 20.68% 22.53%
SG&A Expenses to Revenue		 46.62% 44.64% 45.55% 44.53% 45.72% 43.36% 47.42% 44.40% 42.50% 42.63%
R&D to Revenue		 46.92% 42.58% 43.25% 43.90% 43.28% 40.69% 42.44% 37.73% 40.35% 34.46%
Operating Expenses to Revenue		 402.32% 293.18% 104.58% 103.41% 103.56% 97.26% 102.16% 94.11% 93.28% 89.15%
Earnings before Interest and Taxes (EBIT)		 -400 -299 -34 -35 -31 -30 -9.39 -22 -16 61
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -378 -278 -15 -16 -12 -12 5.23 -7.59 -2.32 74
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.78 1.03 1.28 1.03 1.15 1.27 0.89 1.03 1.01
Price to Tangible Book Value (P/TBV)		 0.00 1.82 2.34 2.82 2.27 2.35 2.49 1.69 1.91 1.63
Price to Revenue (P/Rev)		 0.00 0.72 0.90 1.08 0.80 0.89 0.99 0.68 0.76 0.87
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.70 1.04 1.35 1.04 1.25 1.32 0.87 1.04 1.01
Enterprise Value to Revenue (EV/Rev)		 0.00 0.47 0.75 0.93 0.61 0.68 0.87 0.56 0.68 0.71
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.03
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 25.51
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 53.71
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 5,708.36 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.11 0.12 0.12 0.13 0.13 0.13 0.14 0.14 0.12
Long-Term Debt to Equity		 0.00 0.11 0.12 0.12 0.13 0.13 0.13 0.14 0.00 0.00
Financial Leverage		 0.00 -0.25 -0.14 -0.15 -0.21 -0.26 -0.13 -0.13 -0.14 -0.23
Leverage Ratio		 0.00 1.34 1.60 1.62 1.72 1.69 1.62 1.64 1.73 1.64
Compound Leverage Factor		 0.00 1.33 1.58 1.58 1.79 1.68 1.57 1.60 1.81 1.58
Debt to Total Capital		 0.00% 10.02% 10.40% 10.77% 11.46% 11.44% 11.58% 11.90% 12.32% 10.44%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 12.32% 10.44%
Long-Term Debt to Total Capital		 0.00% 10.02% 10.40% 10.77% 11.46% 11.44% 11.58% 11.90% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% -2.89% -3.20% -3.52% -3.83% -3.91% -4.03% -4.44% -5.32% 0.00%
Common Equity to Total Capital		 0.00% 92.87% 92.79% 92.75% 92.38% 92.47% 92.45% 92.54% 93.00% 89.56%
Debt to EBITDA		 0.00 -0.08 -0.07 -0.07 -0.16 -0.91 -1.41 -1.87 -2.94 0.72
Net Debt to EBITDA		 0.00 0.17 0.09 0.09 0.26 1.67 1.28 1.59 1.34 -1.15
Long-Term Debt to EBITDA		 0.00 -0.08 -0.07 -0.07 -0.16 -0.91 -1.41 -1.87 0.00 0.00
Debt to NOPAT		 0.00 -0.10 -0.09 -0.09 -0.18 -0.55 -0.56 -0.62 -0.70 7.65
Net Debt to NOPAT		 0.00 0.21 0.12 0.12 0.29 1.01 0.50 0.53 0.32 -12.33
Long-Term Debt to NOPAT		 0.00 -0.10 -0.09 -0.09 -0.18 -0.55 -0.56 -0.62 0.00 0.00
Altman Z-Score		 0.00 -0.88 0.53 0.63 0.14 0.19 0.44 -0.13 -0.24 0.58
Noncontrolling Interest Sharing Ratio		 0.00% -1.61% -3.57% -3.94% -4.33% -3.77% -4.03% -4.46% -5.16% -2.09%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 0.00 2.21 2.37 2.26 1.95 1.92 2.10 2.01 1.29 1.64
Quick Ratio		 0.00 1.93 1.99 1.95 1.70 1.59 1.77 1.74 1.09 1.47
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 -393 -377 -327 35 11 9.32 -40 -81
Operating Cash Flow to CapEx		 324.64% -463.36% -1,116.37% -67.91% 722.92% 623.07% -1,119.31% -57.93% -106.92% 28.72%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 -531.62 -502.50 -244.51 201.49 14.32 12.46 -52.64 -106.92
Operating Cash Flow to Interest Expense		 0.00 0.00 -58.25 -2.03 17.99 118.74 -66.56 -2.85 -6.15 1.63
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 -63.46 -5.03 15.50 99.68 -72.51 -7.78 -11.90 -4.03
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.00 0.51 0.74 0.76 0.78 0.74 0.78 0.78 0.79 0.74
Accounts Receivable Turnover		 0.00 3.86 3.65 3.76 4.15 4.17 3.75 3.70 3.73 3.77
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 9.54 10.84 11.02 11.65 11.66 11.56 11.42 11.54 11.48
Accounts Payable Turnover		 0.00 11.06 8.97 11.10 7.85 6.64 7.21 9.21 6.87 6.01
Days Sales Outstanding (DSO)		 0.00 94.63 100.03 97.12 88.03 87.54 97.35 98.63 97.78 96.82
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 32.99 40.71 32.89 46.48 54.94 50.64 39.65 53.16 60.69
Cash Conversion Cycle (CCC)		 0.00 61.63 59.32 64.23 41.55 32.60 46.71 58.98 44.63 36.13
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 0.00 339 370 352 305 283 337 328 332 349
Invested Capital Turnover		 0.00 1.48 2.76 2.90 3.41 1.68 1.45 1.49 1.60 1.56
Increase / (Decrease) in Invested Capital		 0.00 0.00 370 352 305 -56 -33 -25 27 66
Enterprise Value (EV)		 0.00 237 383 474 316 354 444 284 344 351
Market Capitalization		 0.00 362 459 553 414 463 507 345 388 432
Book Value per Share		 $0.00 $11.03 $10.60 $10.13 $9.31 $9.30 $9.02 $8.61 $8.24 $9.57
Tangible Book Value per Share		 $0.00 $4.74 $4.66 $4.60 $4.22 $4.54 $4.59 $4.51 $4.44 $5.92
Total Capital		 0.00 499 481 464 436 437 432 420 406 479
Total Debt		 0.00 50 50 50 50 50 50 50 50 50
Total Long-Term Debt		 0.00 50 50 50 50 50 50 50 0.00 0.00
Net Debt		 0.00 -110 -61 -62 -82 -92 -45 -42 -23 -81
Capital Expenditures (CapEx)		 3.36 3.69 3.86 2.25 3.32 3.32 4.45 3.68 4.35 4.28
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 22 61 49 13 9.72 47 41 35 39
Debt-free Net Working Capital (DFNWC)		 0.00 182 172 161 144 152 143 134 108 170
Net Working Capital (NWC)		 0.00 182 172 161 144 152 143 134 58 120
Net Nonoperating Expense (NNE)		 122 89 9.42 15 20 4.45 -9.26 15 6.84 -78
Net Nonoperating Obligations (NNO)		 0.00 -110 -61 -62 -82 -104 -45 -42 -24 -81
Total Depreciation and Amortization (D&A)		 22 21 19 19 19 18 15 14 14 13
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 4.36% 11.95% 9.53% 2.46% 1.86% 9.23% 8.18% 6.85% 7.89%
Debt-free Net Working Capital to Revenue		 0.00% 36.24% 33.64% 31.49% 27.77% 29.12% 27.78% 26.46% 21.14% 34.34%
Net Working Capital to Revenue		 0.00% 36.24% 33.64% 31.49% 27.77% 29.12% 27.78% 26.46% 11.31% 24.21%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($7.06) ($0.76) ($0.90) ($0.96) ($0.56) ($0.29) ($0.67) ($0.37) $1.02
Adjusted Weighted Average Basic Shares Outstanding		 0.00 42.03M 42.22M 42.77M 43.32M 43.01M 44.52M 45.33M 45.68M 45.06M
Adjusted Diluted Earnings per Share		 $0.00 ($7.06) ($0.76) ($0.90) ($0.96) ($0.56) ($0.29) ($0.67) ($0.37) $1.02
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 42.03M 42.22M 42.77M 43.32M 43.01M 44.52M 45.33M 45.68M 45.06M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 42.08M 42.52M 43.30M 43.47M 44.27M 45.15M 45.81M 44.83M 44.39M
Normalized Net Operating Profit after Tax (NOPAT)		 -32 -29 -23 -25 -22 -20 -23 -15 -13 -8.93
Normalized NOPAT Margin		 -25.98% -21.07% -17.94% -19.41% -16.67% -14.89% -19.04% -12.82% -9.77% -7.29%
Pre Tax Income Margin		 -328.57% -219.10% -26.20% -27.01% -24.84% -21.68% -7.66% -17.87% -12.74% 48.20%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 -45.41 -46.91 -23.24 -171.28 -12.56 -29.29 -21.40 81.00
NOPAT to Interest Expense		 0.00 0.00 -31.78 -32.84 -16.27 -119.90 -30.25 -20.50 -17.18 -20.18
EBIT Less CapEx to Interest Expense		 0.00 0.00 -50.62 -49.91 -25.73 -190.34 -18.50 -34.21 -27.15 75.34
NOPAT Less CapEx to Interest Expense		 0.00 0.00 -37.00 -35.83 -18.76 -138.95 -36.20 -25.43 -22.93 -25.84
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -2,300.35%

Financials Breakdown Chart

Key Financial Trends

Xperi’s latest quarter shows a sharp earnings rebound, but the quality of that improvement is mixed. In Q4 2024, revenue fell to $122.4 million from $132.9 million in Q3 and $137.2 million in Q4 2023, while operating loss improved to $14.3 million from $18.6 million in Q3 and a much worse $299.1 million in Q4 2023, which included a large impairment charge. Net income jumped to $62.9 million, but that result was heavily lifted by $75.5 million in other income, so it does not reflect core operating strength.

The bigger takeaway for investors is that Xperi is still struggling to translate revenue into durable operating profits. Over the last four quarters, operating revenue has been fairly stable in the low-$120 million to low-$130 million range, but operating expenses have remained elevated. SG&A and R&D together continue to consume most of gross profit, keeping the company in operating loss territory despite gross margins that remain decent.

Cash flow improved materially in Q4 2024, but the company is not yet generating consistently strong operating cash flow. Operating cash flow was only $1.2 million in Q4 2024, after a $4.6 million outflow in Q3 and a $2.1 million outflow in Q2. That is better than the deeper cash burn earlier in the year, but it still suggests the business is only barely covering its day-to-day needs from operations.

Xperi’s balance sheet remains a point of relative stability. As of Q3 2024, the company had $72.7 million in cash and equivalents, $616.2 million in assets, and $377.4 million in common equity. Total liabilities were $260.3 million, and long-term debt was $0 in Q3 before rising to $50 million in Q2 2024, so leverage appears manageable, though debt did reappear during the year.

Here are the key positives and negatives from the recent trend:

  • Gross profit remains solid. Q4 2024 gross profit was $95.0 million on $122.4 million of revenue, showing the underlying business still has meaningful margin potential.
  • Operating loss narrowed versus prior quarters. Q4 2024 operating loss of $14.3 million was better than Q3’s $18.6 million loss and far better than Q4 2023’s $299.1 million loss.
  • Cash position is still sizable. Xperi reported $72.7 million of cash at the Q3 2024 balance sheet date, which provides some cushion.
  • Net income turned strongly positive in Q4 2024. The company posted $62.9 million of net income, aided by substantial non-operating income.
  • Share count has trended slightly lower from 2023 to late 2024. Basic shares outstanding fell from roughly 45.2 million in Q1 2024 to 45.1 million in Q4 2024, which supports EPS modestly.
  • Revenue has been relatively stable, not rapidly growing. Quarterly revenue has mostly ranged from about $118.8 million to $137.2 million over the last year and a half.
  • R&D spending remains high. This may support future products, but it also keeps near-term profitability under pressure.
  • Non-operating items had a huge impact on results. Q4 2024 earnings were boosted by $75.5 million of other income, making the headline profit less representative of core operations.
  • Operating results are still negative. Even with the Q4 improvement, the business has not yet produced consistent operating profit.
  • Cash from operations has been inconsistent and weak in 2024. Several quarters showed negative or near-zero operating cash flow, which limits financial flexibility.

Bottom line: Xperi looks financially sturdier than it did during the large impairment-driven losses in late 2023, but the business still needs to prove it can generate consistent operating income and cash flow from its core operations. For retail investors, the stock likely depends on whether management can sustain margin improvement without relying on one-time gains or other income to drive earnings.

06/23/26 10:01 PM ETAI Generated. May Contain Errors.

Xperi Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Xperi's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

Xperi's net income appears to be on a downward trend, with a most recent value of -$869 thousand in 2024, falling from -$141.29 million in 2020. The previous period was -$139.69 million in 2023. Check out Xperi's forecast to explore projected trends and price targets.

Xperi's total operating income in 2024 was -$87.08 million, based on the following breakdown:
  • Total Gross Profit: $379.93 million
  • Total Operating Expenses: $467.01 million

Over the last 4 years, Xperi's total revenue changed from $376.10 million in 2020 to $493.69 million in 2024, a change of 31.3%.

Xperi's total liabilities were at $238.68 million at the end of 2024, a 16.7% decrease from 2023, and a 12.2% increase since 2021.

In the past 3 years, Xperi's cash and equivalents has ranged from $120.70 million in 2021 to $160.13 million in 2022, and is currently $130.56 million as of their latest financial filing in 2024.

Over the last 4 years, Xperi's book value per share changed from 0.00 in 2020 to 9.57 in 2024, a change of 957.1%.


Related Companies

Financial statements for NYSE:XPER last updated on 4/6/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel